Search for: "Mylan Pharmaceuticals, Inc." Results 1 - 20 of 355
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Jan 2020, 8:25 pm by Brianna Smith
Mylan Pharmaceuticals Inc. is recalling certain batches of its Nizatidine Capsules, USP, over concerns they may contain a carcinogen. [read post]
5 Apr 2020, 9:57 pm by Patent Docs
Mylan Pharmaceuticals Inc., the Federal Circuit reversed a decision by the U.S. [read post]
5 Dec 2008, 5:31 am
By Mark Chael -- On December 2nd, Mylan, Inc. and Mylan Pharmaceuticals, Inc. announced that they had settled their dispute with Novartis Pharmaceuticals Corp., Novartis Corp., and Novartis International AG over a generic version of Novartis' Femara ® tablets.According to the press release, Femara ® tablets, which are used in the treatment of breast cancer, had U.S. sales of about $470 million for the 12 months ending… [read post]
10 Jun 2009, 9:02 pm
Seeking approval to market a generic version of levofloxacin, Defendants-Appellants Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc. filed an Abbreviated New Drug Application (ANDA) with the FDA. [read post]
6 Sep 2016, 3:36 pm by Cynthia Marcotte Stamer
The New York Attorney General is investigating whether leading EpiPen Manufacturer, Mylan Pharmaceuticals, violated New York antitrust laws by inserting anticompetitive terms into its EpiPen sales contracts with numerous local school systems. [read post]
22 Jul 2018, 8:32 pm by Patent Docs
Mylan Pharmaceuticals, affirming the decision by the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
14 Feb 2019, 9:50 pm by Patent Docs
RE38,551 challenged in inter partes review were not unpatentable for obviousness, in Mylan Pharmaceuticals Inc. v. [read post]
17 Dec 2008, 5:54 am
The challenges to the '777 patent had been initiated by Defendants-Appellants Mylan Laboratories, Inc., Mylan Pharmaceuticals, Inc., and UDL Laboratories, Inc. [read post]
12 Dec 2011, 9:59 pm by Patent Docs
Mylan Pharmaceuticals Inc., an ANDA case brought before Judge Martini in the New Jersey District Court. [read post]
18 Oct 2009, 5:42 pm
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...] [read post]
20 Aug 2017, 7:14 am by Gregory J. Brod
Pharmaceutical companies Mylan Inc. and Mylan Specialty L.P. agree to pay $465 million to settle a lawsuit brought under the False Claims Act (FCA). [read post]
24 Oct 2008, 11:37 am
Swiss-drug major Novartis has filed a lawsuit in the US District Court for the District of New Jersey against Mylan Pharmaceuticals Inc. for infringement of Orange Book listed US Patent No. 5,354,772 (the ‘772 patent) for Lescol capsules, generically known as Fluvastatin Sodium. [read post]
25 Aug 2017, 2:25 pm by taotiadmin
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]